Što ljudi govore - Napišite recenziju
Na uobičajenim mjestima nismo pronašli nikakve recenzije.
Ostala izdanja - Prikaži sve
action Agency approved asked Association assurance batch believe bioequivalence bottles brand Buffalo Bureau of Drugs Code Commissioner complaints compliance concerned contained continue copy correct COUNT MFRNAME COUNT DATE Defect DEPARTMENT Director discuss distribution District Division Drug Administration drug products effect ESTABLISHMENT facility fact Federal FILE firm firm's Food and Drug FORM further HEALTH indicated Init Injection inspection involved issue labeling Laboratories Labs letter Luther manufacturing matter meeting MFRNAME COUNT MFRNAME Norwich noted OFFICE operations patient percent Pharmaceutical pharmacists physicians planned plant practice present problems prosecution question REASON recall received recommendation record referred regard regulations Rensselaer reports representatives request response Rx Rx samples Senator NELSON specific Squibb standards statement Sterling Drug STETLER Tablets testing told TYPE units York
Stranica 16360 - for training including apprenticeship. F. The Contractor shall, in all solicitations or advertisements for employees placed by or on behalf of the Contractor state that all qualified applicants will receive consideration for employment without discrimination based on age, race, color, creed, national origin, sex, or condition of physical
Stranica 16561 - Its history and current pattern of abuse. 5. The scope, duration and significance of abuse. 6. What, If any, risk there is to the public health. 7- Its psychic or physiological dependence liability. 8. Whether the substance is an Immediate precursor of a substance already controlled under this subchapter. 121 USC
Stranica 16570 - and (b)(2). 109. 21 USC § 812. The findings required for Schedules II and IV are as follows: (2) Schedule II (A) The drug or other substance has a high potential for abuse. (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. CC) Abuse of
Stranica 16878 - (2) that has 'a currently accepted medical use in treatment in the United States, or a currently accepted medical use with severe restrictions,' and "(3) for which abuse may lead to 'severe psychological or physical dependence.
Stranica 16561 - To provide guidance to the Attorney General, the statute further states that the Attorney General's inquiry must include an evaluation of the following factors: 1. Its actual or relative potential for abuse. 2. Scientific evidence of Its pharmacological effect, If known. 3. The state of current scientific knowledge regarding the drug or other substance.
Stranica 16264 - CONGRESS, IST SESSION WASHINGTON, D,C. NOVEMBER 15, 1977 American Pharmaceutical Association 2215 Constitution Avenue, NW Washington, DC 20037 (202) 628-4410 MR. CHAIRMAN; MEMBERS OF THE SUBCOMMITTEE: I AM DR. WILLIAM S, APPLE, EXECUTIVE DiRECTOR OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, THE NATIONAL PROFESSIONAL SOCIETY OF PHARMACISTS IN THE UNITED STATES. ACCOMPANYING ME
Stranica 16565 - Report to Drug Addiction Committee 20 April 1956, Addendum to Minutes of the 17th Meeting of the Committee on Drug Addiction and Narcotics of the National Research Council," Washington, DC 30-31 January 1956. 2. See, eg, Gruber, CM, "Codeine Phosphate, Propoxyphene
Stranica 16777 - PROPOXYPHENE :; Mr. Chairman, in your letter of invitation you asked me to comment on the reasons for the sustained popularity of propoxyphene as an analgesic ;:. in view of Its limited effectiveness. The answer to this question Is complex and involves a number of factors. First, I would point out that a significant number of
Stranica 16859 - 4) :65, 1967. 9. Lim, RKS, et al.: Site of Action of Narcotic and Non-Narcotic Analgesics Determined by Blocking Bradykinin-Evoked Visceral Pain, Arch. Int. Pharmacodyn., 152(1-2) : 25-58,1964. 10. Lorenzetti, OJ, and Sancilio, LF: Morphine Dependent Rats as a Model for Evaluating Potential Addiction Liability of Analgesic Compounds, Arch. Int. Pharmacodyn., 183:391-402,1970.
Stranica 16202 - be sterile which are adulterated within the meaning of 21 USC 351(a)(2)(B) in that the methods used in and the facilities and controls used for the manufacturing, processing, packing, or holding of said articles do not conform to and